Loading market dashboard
enCore Energy Corp.
EUEnergyNASDAQUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
NASDAQ:EUTSXV:EU www.encoreuranium.com DALLAS, June 4, 2026 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, today announced the completion of the first phase of construction on the Upper Spring Creek In-Situ Recovery ("ISR") Uranium Project (the "Project")'s Satellite Remote Ion Exchange ("IX") Plant. Construction of the first production wellfield, which will feed the IX Plant, is also nearing completion and will begin uranium extraction once final permits are received.
A new study detailing the scale of the illicit cigarette trade in the European Union (EU) shows that consumption of black-market cigarettes rose more than 7% y
Cemex, S.A.B. de C.V. (âCemexâ) (NYSE: CX) announced today the pricing of U.S.$1.5 billion of its 5.750% Senior Notes due 2036 (the âNotesâ). The Notes
Sumo Logic Now Available on AWS Region European Sovereign Cloud to Support Security and Data Sovereignty PR Newswire
Universal Music Group N.V. Reports Weekly Transactions under its â¬500 Million Share Buyback Program PR Newswire
/PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy CompanyTM, today shared positive results from
ICL Group Ltd. (NYSE and TASE: ICL)(the âCompanyâ or âICLâ) hereby announces that it has commenced an offering (the âOfferingâ) of new unsecured seni
AstraZeneca's IMFINZIÂ (durvalumab) in combination with Bacillus Calmette-GuÃrin (BCG) induction and maintenance therapy has been approved in the US for the
Universal Music Group N.V. Reports Weekly Transactions under its â¬500 Million Share Buyback Program PR Newswire
Saba Capital Management, L.P. (together with certain of its affiliates, âSabaâ or âweâ), the largest shareholder of Schroder UK Mid Cap Fund plc (SCP: L
Hansa Biopharma enters into â¬115 million licensing agreement with SERB Pharmaceuticals for IDEFIRIX in Europe and MENA PR New
NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS, April 20, 2026 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today that the independent members of its Board of Directors have unanimously voted to appoint Richard H. Little as Chief Executive Officer, replacing Robert Willette, effective immediately.
NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS, March 9, 2026 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy CompanyTM, announced today its financial and operational results for the year ended December 31, 2025. "Our year end results underscore the strength of enCore's operational performance," said Rob Willette, Chief Executive Officer of enCore.
